News

Codagenix, Serum Institute of India to co-develop scalable, live-attenuated vaccine against Novel Coronavirus, COVID-19

Codagenix and Serum Institute are pursuing an accelerated development pathway with built-in redundancies to increase speed and likelihood of success.

Feb 14, 2020

By : Team ABLE

FICCI-NATHEALTH sign MoU to strengthen healthcare systems

The MoU aims to provide a wider representation of the healthcare industry to key stakeholders in areas of policymaking and creating a suitable environment to benefit all stakeholders.

Feb 14, 2020

By : Team ABLE

Thermo Fisher Scientific collaborates NanoPin to advance blood-based infectious disease detection technology

Through NanoPin's diagnostic platform usingThermo Fisher'sadvanced LC-MS technology will lead to the development of sensitive clinical assays

Feb 14, 2020

By : Team ABLE

IIMR Hyderabad signs MoU with NSR to produce biofuel from millets

To promote bioethanol production by developing varieties of sweet sorghum, ICAR-IIMR, Hyderabad and National Sugar Institute (NSR), Kanpur have signed an MoU.

Feb 14, 2020

By : Team ABLE

Bayer, Meiogenix collaborate to accelerate agricultural innovation

The collaboration aims to advance agricultural research and development by accelerating the development of Meiogenix’s technologies related to plant breeding and genome editing applications

Feb 12, 2020

By : Team ABLE